Trial site
Saint Luke's Cancer Institute
- 18running trials
- 7closed trials
The trials here
What the 25 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer13 trials
- Colorectal cancer3 trials
- Glioblastoma3 trials
- Lung cancer3 trials
- Bladder cancer2 trials
- Endometrial cancer2 trials
- Gastric and oesophageal cancer2 trials
- Head and neck cancer2 trials
- Kidney cancer2 trials
- Liver and biliary tract cancer2 trials
- Ovarian cancer2 trials
- Pancreatic cancer2 trials
- and 13 more
- Phase
- Phase 313 trials
- Phase 25 trials
- Phase 1/23 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Recruiting10 trials
- Active, not recruiting6 trials
- Completed6 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Pfizer4 trials
- Eli Lilly and Company2 trials
- NuvOx LLC2 trials
- Bristol-Myers Squibb1 trial
- Carrick Therapeutics Limited1 trial
- and 15 more
Running trials
Recruiting
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Enrolling by invitation
Liquid Biopsy in Glioblastoma Treated With Chemoradiation and an Oxygen Therapeutic
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM
Active, not recruiting
Active, not recruiting
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer6 recruiting
- Bladder cancer2 recruiting
- Colorectal cancer2 recruiting
- Endometrial cancer2 recruiting
- Gastric and oesophageal cancer2 recruiting
- Head and neck cancer2 recruiting
- Liver and biliary tract cancer2 recruiting
- Lung cancer2 recruiting
- Ovarian cancer2 recruiting
- Pancreatic cancer2 recruiting
- Brain metastases1 recruiting
- Cervical cancer1 recruiting
- Glioblastoma1 recruiting
- Kidney cancer1 recruiting
- Melanoma1 recruiting
- Mesothelioma1 recruiting
- Multiple myeloma1 recruiting
- Neuroendocrine tumours1 recruiting
- Prostate cancer1 recruiting
- Sarcoma1 recruiting
- Testicular cancer1 recruiting
- Thymoma and thymic carcinoma1 recruiting
- Thyroid cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Site data: ClinicalTrials.govUpdated 19 Nov 2026